Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.6297C>G | p.Cys2099Trp | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TGC | Cys | TGG | Trp | C->G | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
TGFBP#06 | C in disulfide bonds 2084-2099 | Yes, coding strand | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): Hae III, Sau96 I Lost restriction site(s): BspW I |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
1 | 0.17 (non pathogenous) | 94 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
UKD01EDI F0013 I01 | Proband | Male | familial | ? (21 years old) | U.K. |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Aortic insufficiency |
C-Mitral regurgitation |
O-Myopia |
O-Retinal degeneration |
S-Arachnodactyly (M) |
S-Characteristic facial appearance |
S-Joint hypermobility (m) |
S-Joint limitations |
Reference ID | PubMed ID | Reference |
41 | 9338581 | Hayward C, Porteous ME, Brock DJ. "Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: report of 12 novel mutations". Hum Mutat 1997;10(4):280-9 . |